TrialBMC cancer2022

Three-arm phase II trial comparing camrelizumab plus chemotherapy versus camrelizumab plus chemoradiation versus chemoradiation as preoperative treatment for locally advanced esophageal squamous cell carcinoma (NICE-2 Study).

Yang Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.